CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- ScaleMarket cap is $3.21B, above the global median of $1.14B
- FinancialsAltman Z-Score 2.72: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.41%Below 5Y avg (1.74%)
Annual Rate
CNY 0.16Paid annual
Payout Ratio
77.8%Moderate
Payback Period
74.0 yr
Last Ex-Dividend
Oct 21, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
21.37BCNY3.21B · vs all stocks (USD)
Trailing P/E
26.79xvs Medical Devices peers
Revenue (TTM)
6.33BCNY951.22M · vs all stocks (USD)
Profit Margin
12.18%vs Medical Devices peers
Beta
0.0550xvs all stocks
52-Week Change
-33.20%vs all stocks
Market Capitalization
21.37BCNY3.21B · vs all stocks (USD)
Enterprise Value
24.15BCNY3.63B · vs all stocks (USD)
Trailing P/E
26.79xvs Medical Devices peers
Forward P/E
15.62xvs Medical Devices peers
Price to Sales (TTM)
3.28xvs Medical Devices peers
Price to Book (MRQ)
1.26xvs Medical Devices peers
Enterprise to Revenue
3.82xvs Medical Devices peers
Enterprise to EBITDA
15.48xvs Medical Devices peers
Gross Margin
59.58%vs Medical Devices peers
Profit Margin
12.18%vs Medical Devices peers
Operating Margin
14.17%vs Medical Devices peers
Return on Assets (TTM)
2.34%vs Medical Devices peers
Return on Equity (TTM)
4.40%vs Medical Devices peers
Revenue (TTM)
6.33BCNY951.22M · vs all stocks (USD)
Revenue per Share (TTM)
3.43CNYUpdated Oct 20, 2026Quarterly Revenue Growth
-5.60%vs Medical Devices peers
Gross Profit (TTM)
3.83BCNY576.25M · vs all stocks (USD)
EBITDA (TTM)
1.39BCNY209.44M · vs all stocks (USD)
Net Income (TTM)
770.56MCNY115.84M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-19.10%vs Medical Devices peers
Operating Cash Flow (TTM)
1.51BCNY227.47M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
514.39MCNY77.33M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.1628CNYUpdated Oct 20, 2026Trailing Annual Dividend Yield
1.41%vs all stocks
5-Year Average Dividend Yield
1.74%vs all stocks
Payout Ratio
77.85%vs Medical Devices peers
Minority Interest (Equity)
1.64BCNYFY2025 · Dec 31, 2025Revenue
6.48BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
2.33BCNYFY2025 · Dec 31, 2025Gross Profit
4.15BCNYFY2025 · Dec 31, 2025Operating Income
1.54BCNY231.30M · vs all stocks (USD)
Pre-tax Income
1.22BCNYFY2025 · Dec 31, 2025Income Tax Expense
197.07MCNYFY2025 · Dec 31, 2025Net Income
1.02BCNYFY2025 · Dec 31, 2025EBIT
1.39BCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
2.24BCNYFY2025 · Dec 31, 2025Research & Development
792.38MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
787.65MCNYFY2025 · Dec 31, 2025Other Operating Expenses
86.07MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
71.51MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
176.64MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.5219CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.5219CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
1.84BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
1.84BSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
1.02BCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-57.00MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
550.35MCNYFY2025 · Dec 31, 2025Free Cash Flow
-91.08MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
4.34BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
1.02BCNYFY2025 · Dec 31, 2025Other Non-cash Items
260.10MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-489.63MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-239.12MCNYFY2025 · Dec 31, 2025Capital Expenditures
-641.43MCNYFY2025 · Dec 31, 2025Net Acquisitions
2.90MCNYFY2025 · Dec 31, 2025Purchase of Investments
-1.07BCNYFY2025 · Dec 31, 2025Sale of Investments
896.96MCNYFY2025 · Dec 31, 2025Other Investing Activity
116.74MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-690.74MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
3.15BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-2.52BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-681.55MCNYFY2025 · Dec 31, 2025Other Financing Charges
32.63MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-17.67MCNYFY2025 · Dec 31, 2025Shares Outstanding
1.84BSharesUpdated Oct 20, 2026Float Shares
1.12BSharesUpdated Oct 20, 2026% Held by Insiders
38.53%vs all stocks
% Held by Institutions
6.75%vs all stocks
Total Cash (MRQ)
4.41BCNY662.98M · vs all stocks (USD)
Total Cash per Share (MRQ)
2.39CNYUpdated Oct 20, 2026Total Debt (MRQ)
6.35BCNY955.35M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.3558xvs Medical Devices peers
Current Ratio (MRQ)
2.29xvs Medical Devices peers
Book Value per Share (MRQ)
8.89CNYUpdated Oct 20, 2026Total Assets
26.14BCNY3.93B · vs all stocks (USD)
Total Current Assets
10.00BCNYFY2025 · Dec 31, 2025Total Liabilities
8.38BCNYFY2025 · Dec 31, 2025Total Non-current Assets
16.14BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
3.42BCNYFY2025 · Dec 31, 2025Total Current Liabilities
4.96BCNYFY2025 · Dec 31, 2025Cash
4.11BCNYFY2025 · Dec 31, 2025Cash Equivalents
316.72MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
4.43BCNYFY2025 · Dec 31, 2025Other Short-term Investments
203.31MCNYFY2025 · Dec 31, 2025Accounts Receivable
1.99BCNYFY2025 · Dec 31, 2025Inventory
2.02BCNYFY2025 · Dec 31, 2025Accounts Payable
755.04MCNYFY2025 · Dec 31, 2025Short-term Debt
3.25BCNYFY2025 · Dec 31, 2025Other Current Liabilities
79.94MCNYFY2025 · Dec 31, 2025Long-term Debt
3.13BCNYFY2025 · Dec 31, 2025Common Stock (Book)
1.84BCNYFY2025 · Dec 31, 2025Retained Earnings
9.99BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
17.76BCNY2.67B · vs all stocks (USD)
52-Week Low
11.01CNYUpdated Oct 20, 202652-Week High
21.60CNYUpdated Oct 20, 202652-Week Change
-33.20%vs all stocks
Beta
0.0550xvs all stocks
50-Day MA
11.83CNYUpdated Oct 20, 2026200-Day MA
14.38CNYUpdated Oct 20, 2026Avg 10-Day Volume
14.54MSharesUpdated Oct 20, 2026Avg 30-Day Volume
13.48MSharesUpdated Oct 20, 2026Diluted EPS (TTM)
0.4200CNYUpdated Oct 20, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 2.72: safe zoneNotable
Altman Z-Score: 2.72
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Scale
Market cap is $3.21B, above the global median of $1.14BNotable
Market cap (USD): 3,211,844,415.211Global Median: 1,138,450,684.034
Revenue is $951.22M, above the global median of $562.3MNotable
Revenue (USD): 951,219,275.812Global Median: 562,304,852.367
Levered free cash flow is $77.33M, above the global median of $18.69MNotable
Levered free cash flow (USD): 77,328,645.571Global Median: 18,689,872.41
Companies that share the same coordination system — how they create, deliver, or capture value.
Celcuity Inc.
Tier 1ProductionApproval-Gated PipelineRule
Viking Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Ideaya Biosciences Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Wockhardt Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Tarsus Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Jiangsu Nhwa Pharmaceutical Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Walvax Biotechnology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Tasly Pharmaceutical Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Shandong Weigao Blood Purification Products Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Jilin Aodong Pharmaceutical Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule